Introduction Cannabis rescheduling to Schedule III would shift regulatory control and reshape biotech research and crop oversight. Rescheduling marijuana to Schedule III would move oversight from DEA-only research controls to shared DEA, FDA, and USDA authority, changing who approves edited plants and microbial cannabinoids. Few policy...

Introduction If you live with chronic low back pain, VER-01 could offer faster access to a non-opioid treatment option and a potential alternative to opioids. VER-01 is a standardized cannabinoid based investigational therapy developed by VERTANICAL for chronic low back pain. Randomized Phase 3 trials showed significant pain reduction...